Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations
- PMID: 10699051
- PMCID: PMC1734540
- DOI: 10.1136/jmg.37.3.168
Diagnostic analysis of the Rubinstein-Taybi syndrome: five cosmids should be used for microdeletion detection and low number of protein truncating mutations
Abstract
Rubinstein-Taybi syndrome (RTS) is a malformation syndrome characterised by facial abnormalities, broad thumbs, broad big toes, and mental retardation. In a subset of RTS patients, microdeletions, translocations, and inversions involving chromosome band 16p13.3 can be detected. We have previously shown that disruption of the human CREB binding protein (CREBBP or CBP) gene, either by these gross chromosomal rearrangements or by point mutations, leads to RTS. CBP is a large nuclear protein involved in transcription regulation, chromatin remodelling, and the integration of several different signal transduction pathways. Here we report diagnostic analysis of CBP in 194 RTS patients, divided into several subsets. In one case the mother is also suspect of having RTS. Analyses of the entire CBP gene by the protein truncation test showed 4/37 truncating mutations. Two point mutations, one 11 bp deletion, and one mutation affecting the splicing of the second exon were detected by subsequent sequencing. Screening the CBP gene for larger deletions, by using different cosmid probes in FISH, showed 14/171 microdeletions. Using five cosmid probes that contain the entire gene, we found 8/89 microdeletions of which 4/8 were 5' or interstitial. This last subset of microdeletions would not have been detected using the commonly used 3' probe RT1, showing the necessity of using all five probes.
Similar articles
-
Submicroscopic deletion of chromosome 16p13.3 in patients with Rubinstein-Taybi syndrome.Am J Med Genet. 1998 Jul 7;78(3):267-70. Am J Med Genet. 1998. PMID: 9677064
-
Analysis of CBP (CREBBP) gene deletions in Rubinstein-Taybi syndrome patients using real-time quantitative PCR.Hum Mutat. 2004 Mar;23(3):278-84. doi: 10.1002/humu.20001. Hum Mutat. 2004. PMID: 14974086
-
Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP.Nature. 1995 Jul 27;376(6538):348-51. doi: 10.1038/376348a0. Nature. 1995. PMID: 7630403
-
[Rubinstein-Taybi syndrome].Arch Pediatr. 1994 Jul;1(7):681-3. Arch Pediatr. 1994. PMID: 7987469 Review. French.
-
[Clinical sequelae of mutation of the CBP gene].Cas Lek Cesk. 1999 Dec 13;138(24):739-43. Cas Lek Cesk. 1999. PMID: 10746038 Review. Czech.
Cited by
-
Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire.Hum Genet. 2015 Jun;134(6):613-26. doi: 10.1007/s00439-015-1542-9. Epub 2015 Mar 25. Hum Genet. 2015. PMID: 25805166 Clinical Trial.
-
Evidence for a new contiguous gene syndrome, the chromosome 16p13.3 deletion syndrome alias severe Rubinstein-Taybi syndrome.Hum Genet. 2006 Sep;120(2):179-86. doi: 10.1007/s00439-006-0215-0. Epub 2006 Jun 17. Hum Genet. 2006. PMID: 16783566
-
X-linked mental retardation and epigenetics.J Cell Mol Med. 2006 Oct-Dec;10(4):808-25. doi: 10.1111/j.1582-4934.2006.tb00526.x. J Cell Mol Med. 2006. PMID: 17125586 Free PMC article. Review.
-
Rubinstein-taybi syndrome: a female patient with a de novo reciprocal translocation t(2; 16)(q36.3; p13.3) and dysgranulopoiesis.Clinics (Sao Paulo). 2010;65(1):107-9. doi: 10.1590/S1807-59322010000100016. Clinics (Sao Paulo). 2010. PMID: 20126353 Free PMC article. No abstract available.
-
Perioperative management of a patient of Rubinstein-Taybi syndrome with ovarian cyst for laparotomy.J Anaesthesiol Clin Pharmacol. 2014 Jul;30(3):422-4. doi: 10.4103/0970-9185.137285. J Anaesthesiol Clin Pharmacol. 2014. PMID: 25190959 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources